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Abstract
Ayahuasca is a psychedelic decoction originating from Amazonia. The 
ayahuasca-induced introspective experience has been shown to have potential 
benefits in the treatment of several pathologies, to protect mental health and to 
improve neuropsychological functions and creativity, and boost mindfulness. 
The underlying psychological processes related to the use of ayahuasca in a 
psychotherapeutic context are not yet well described in the scientific literature, 
but there is some evidence to suggest that psychological variables described in 
psychotherapies could be useful in explaining the therapeutic effects of the 
brew. In this study we explore the link between ayahuasca use and Decentering, 
Values and Self, comparing subjects without experience of ayahuasca (n=41) 
with subjects with experience (n=81). Results confirm that ayahuasca users 
scored higher than non-users in Decentering and Positive self, but not in Valued 
living, Life fulfilment, Self in social relations, Self in close relations and General 
self. Scores in Decentering were higher in the more experienced subjects (more 
than 15 occasions) than in those with less experience (less than 15 occasions). 
Our results show that psychological process variables may explain the 
outcomes in ayahuasca psychotherapy. The introduction of these variables is
warranted in future ayahuasca therapeutic studies.  
Key words: Ayahuasca; Psychedelics; Decentering; Values; Self; 
Psychotherapy; Contextual therapy. 
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1. Introduction
Ayahuasca is the name assigned to both the Amazonian liana Banisteriopsis 
caapi and any type of decoction containing it (Sánchez and Bouso, 2015). In 
some Amazonian regions where the use of ayahuasca is considered a tradition, 
decoctions also include leaves from Psychotrotria viridis (Rubiaceae) or from 
Diplopterys cabrerana (Malpighiaceae). B. caapi contains harmala alkaloids 
(harmine, harmaline and tetrahydroharmine), which act as MAOI‟s (monoamine 
oxidase inhibitors) and P. viridis and D. cabrerana contain the alkaloid DMT
(N,N-Dimethyltryptamine) associated with visionary effects. The combination of
both plants results in MAO inhibition due to beta-carboline activity, blocking 
DMT degradation in the gastrointestinal tract, which allows for uptake by the 
brain (Riba et al., 2015)  
Ayahuasca is used by indigenous Amazonians for ritualistic, religious and 
ethnomedical purposes (Schultes and Farnsworth, 1980). In recent decades its 
use has reached an international sphere, it being use for religious, therapeutic 
and personal growth purposes (Labate and Feeney, 2012). Ayahuasca induces 
an altered state of consciousness with introspective effects and oneiric-like 
visions including autobiographic and emotional memories and transpersonal 
experiences (Bouso and Riba, 2011). 
The ayahuasca-induced introspective experience has been shown to have 
potential benefits for the improvement of several pathologies such as addiction 
(Nunes et al., 2016; Thomas et al., 2013; Fernández et al., 2014), treatment-
resistant depression (Osório et al., 2015; Sanches et al., 2016) and suicidal and 
aggressive behavior (Frecska, 2008; Grob et al., 1996). Ayahuasca also 
displays potential mental health protection (Bouso et al., 2012; Grob et al., 
1996; Halpern et al., 2008), improved neuropsychological functions (Bouso 
et al., 2012, 2015; Bouso et al., 2013) and improved creativity (Frecska et al., 
2012; Kuypers et al., 2016). Also, cortical thickness in long-term ayahuasca 
users has been correlated with cognitive capacities and personality traits 
(Bouso et al., 2015). Potential risks or negative side effects of ayahuasca use 
when it is used in a safe and supportive setting appear to be negligible. In fact, 
in none of the studies comparing long-term ritual ayahuasca users with 
ayahuasca-abstaining controls have worse scores in either psychopathological 
status or in neuropsychological functioning in ayahuasca users (for a review see 
dos Santos et al, 2016a) been observed. However there is some anecdotal 
evidence linking ayahuasca use to negative effects. A recent report described 
several deaths that occurred in retreat centers in South America, but none of
them seem to be directly related to physiological effects of ayahuasca but with 
physical accidents or crime (Bauer, 2018). A recent systematic review published 
by our group found three case series and two case reports describing psychotic 
episodes associated with ayahuasca intake (dos Santos et al., 2017). The 
incidence of observed psychosis related to ayahuasca use is within the estimate 
for the general population (Lima et al., 2002). 
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The underlying psychological processes related to the use of ayahuasca are not 
well described yet in the scientific literature, but there is some evidence 
suggesting that variables such as Decentering, Values and those related to the 
Self could be useful to explain the therapeutic effects of the decoction 
(Fernández et al., 2014; Soler et al., 2016; Thomas et al., 2013). Stories about 
subjective perception of ayahuasca benefits usually include references to “ego 
dissolution”, “higher consciousness of important things”, “contact with oneself”, 
“improved ability to understand others”, “greater acceptance of oneself and life 
events”, “capacity of self-observation”, and other similar processes related to 
personal growth (Bresnick and Levin, 2006).  
Decentering is defined as “the ability to observe one‟s thoughts and feelings in a 
detached manner, as temporary events in the mind, as neither necessarily true 
nor reflections of the self” (Kerr et al., 2011; Safran and Segal, 1990). 
Decentering is a relevant construct since it has been pointed out as necessary 
for healthy cognitive, psychological, and social functioning (Fresco et al., 2007) 
and could be considered as a transdiagnostic vulnerability factor shared among 
several mental disorders (Soler et al., 2014). Indeed, high levels of cognitive 
fusion at baseline predicted earlier relapse in subjects who had recently 
suffered from major depression (Teasdale et al., 2002) and, along with 
depression, low levels of Decentering has been observed in subjects suffering 
from borderline personality disorder, eating behaviour disorder and cocaine 
dependence (Soler et al., 2014).  
 
Regarding Values, interventions focused on the work of personal values 
demonstrated improved response to stressors (Branstetter-Rost et al., 2009; 
Gregg et al., 2014) and quality of life (McCracken, 2013; Michelson et al., 2011). 
Shanon (2003) described the attribution of meaning as an effect of ayahuasca 
on consciousness, particularly aesthetic and transcendent value and 
transcendent experiences, which are hypothesized by Liester and Prickett 
(2012) as an important mechanism in the treatment of addictions. Bouso et al. 
(2012) found higher scores for spiritual orientation and purpose in life in 
ayahuasca users and Fernández et al. (2014) found positive changes in life 
attitudes and values in people who received ayahuasca together with 
psychotherapy in treatment of drug addiction. In this study “Values” are 
conceptualized from a contextual approach as patterns of activity, which are 
constructed as a result of verbal stimuli that establish reinforcing psychological 
functions (Wilson et al., 2010). Values could be considered as chosen life 
directions in this sense giving life meaning and purpose and guiding some 
behaviors (Hayes et al., 2005).  
 
Related to the Self, contextual psychotherapies, especially functional analytic 
psychotherapy (Kolhenberg and Tsai 2007), define the self as a private 
experience of the individual. This experience of “you” that is observing is what 
we refer as a “self”, a central something that is witness to all events, internal or 
external (Tsai et al. 2009). During the development, the individual learns how to 
associate internal states with “I” or “me”, but in some cases (for example, in 
invalidating environments) this association can be altered and the self is 
associated to external stimulus or to a public control. There is a relationship 
between the public control of the self and variables such as low self-esteem or 
high dissociation (Kanter et al., 2001). Also, clinical samples show higher public 
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control of the self than control samples (Kanter et al., 2001; Valero-Aguayo et 
al., 2014). Positive self, referred to positive concepts about one's self, 
specifically creativity and spontaneity, is also related to wellbeing and is 
reflected in lower scores in a clinical sample than a non clinical sample (Valero-
Aguayo et al., 2014). Past literature has described the effects of ayahuasca on 
self. Shanon (2003) described phenomenological increases in self-
consciousness, changes in the locus of consciousness, in the perceived 
boundaries of the self and in personal identity. Also Thomas et al. (2013) 
described a correlation between ayahuasca-assisted therapy for drug addiction 
treatment and subjective feelings of connection with self. In fact, psychedelics 
induce a robust effect on “ego-dissolution”, a specific psychological effect that is 
related with mystical experiences (Lebedev et al., 2015) and therapeutic effects 
(Carhart-Harris et al., 2018). Controlled studies where subjects achieved 
mystical experiences under the effects of psilocybin showed personal long-term 
benefits (Griffiths et al., 2008; Griffiths et al., 2011). “Positive self” referred to 
the capacity to be creative and spontaneous and being comfortable while alone 
and also in social environments. This is related to the increased cognitive 
flexibility and could facilitate adaptation to the context, the main objective of 
most psychotherapies. Previous studies described increases in divergent 
thinking during the ayahuasca intake (Kuypers 2016) and visual creativity after 
ritual use of ayahuasca (Frecska 2012). Positive self, is also related to 
wellbeing and a clinical sample showed lower scores  than a non clinical sample 
(Valero-Aguayo et al., 2014). 
 
Decentering, values, positive self and public control of the self are all variables 
related to psychological wellbeing and a focus of change in psychotherapeutic 
interventions. In this study we explore the link between ayahuasca use and 
Decentering, Values, and the Public control of self with the aim of characterizing 
the eventual factors that may explain the therapeutic potential of ayahuasca. 
For achieving this objective, we compared ayahuasca users with non-users 
using the aforementioned variables. We hypothesize higher scores in 
Decentering, Values and Positive self among ayahuasca users and lower 
scores in Public control of self. We also explored whether eventual changes in 
psychological processes are related to the frequency of ayahuasca use.  
 
2. Methods 
2.1. Participants and study procedure 
122 participants completed the assessment scales. From the total participants, 
41 had never used ayahuasca (non-users) and 81 had used ayahuasca 
between 1 and over a 100 times. The ayahuasca group was recruited from 
associations and collectives of ayahuasca users using the brew for therapeutic, 
religious or personal growth purposes. All the contextual settings consisted of 
group ceremonies or sessions. In the therapeutic and/or personal growth 
settings, the ceremonies usually were guided by a facilitator (generally a 
psychologist) who previously learnt how to guide ayahuasca sessions in South 
America. This is a typical setting in most of the ayahuasca ceremonies that take 
place in Catalonia, the Spanish region where subjects were recruited (Apud & 
Romaní, 2017). The subjects recruited from religious groups belonged to local 
groups of the Santo Daime church, an ayahuasca church originally based in 
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Brazil, which has expanded internationally in recent years (Labate et al., 2009). 
Thus, the contextual settings of the subjects were always ayahuasca-ritualized 
ceremonies. None of our subjects took ayahuasca just for recreational purposes 
or in recreational settings. 
The study was conducted in accordance with the Declaration of Helsinki and 
subsequent amendments concerning research in humans and was approved by 
the Unió Catalana d‟Hospitals Ethics Committee. All volunteers provided their 
written informed consent to participate.  
2.2. Questionnaires 
2.2.1. Descriptive variables: 
- Sociodemographic variables: Age, gender, education level, ayahuasca 
use history, drug history and psychiatric medication. 
- Brief Symptom Inventory 18 (BSI-18) (Derogatis, 2001) is a self-report 
scale that measures psychological distress. Items are rated with a Likert-type 
scale from 0 (nothing) to 4 (completely). Items are referred to symptoms 
experienced during the last 7 days. This scale is scored by adding the 18 items 
to a global severity index and also scores three subscales with six items each: 
somatization, depression and anxiety. For this study we used the Spanish 
version by Derogatis (2014). 
- Psychoticism scale of the Symptoms Assessment-45 (SA-45-
psychoticism) (Davison et al., 1997): has five items related to the last seven 
days experience measured with a Likert-type scale rated from 0 (nothing) to 4 
(completely). For this study we used the Spanish version by Sandín et al. 
(2008). 
2.2.2. Psychological processes variables: 
- Experiences Questionnaire (EQ) (Fresco et al., 2007) was designed to 
measure Decentering and rumination. It has 11 items measured with a Likert 
scale rating from 1 to 5. For this study we used the Spanish version by Soler et 
al. (2014). 
- Engaged Living Scale (ELS) (Trompetter et al., 2013) is a self-report 
measure with 16 items in a Likert-type scale scoring from 1 to 5. It has two 
subscales: Valued Living (10 items) and Life Fulfilment (6 items). The scores on 
Valued Living reflect the recognition and knowledge of personal values and the 
undertaking of behavioural actions congruent with these values. The Life 
Fulfilment subscale is composed of items measuring the sense of fulfilment in 
life as a consequence of recognizing and living in accordance with personal 
values. For this study we used the Spanish version by Domínguez et al. (2014). 
 
- The Experiencing of Self Scale (EOSS) (Kanter et al., 2001) is a 
measurement of the public control of the experience of the self and measures to 
what degree other people influence it. It has 37 items rated in a Likert-type 
scale rating from 1 to 7. EOSS assesses the self as a private experience with 
three factors about experiences of the self: in intimate relationships, in casual 
acquaintances, or a “general self”; with items which refer in all cases to a public 
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control of self. Also, the EOSS factor of “positive self” contains items about 
experiences of well-being, specifically creativity and spontaneity.  For this study 
we used the Spanish version by Valero-Aguayo et al. (2014). 
 
2.3. Statistical analysis 
First, we compared the sociodemographic and descriptive variables between 
the non-ayahuasca using group and the ayahuasca using group. For categorical 
variables we used chi square test and t-test for quantitative variables. We also 
compared the two groups in history of substance use with a chi square test and 
psychopathology indexes with a t-test. Decentering, Values and Public control 
of the experience of self were compared between groups using a t-test for 
independent samples.  
Subsequently, to study differences between subjects with low and high 
ayahuasca use experience, we reorganized subjects in three groups: non-users, 
subjects with more than 1 ayahuasca experience but less than 15 (AYA 1-15), 
and subjects with more than 15 ayahuasca experiences (AYA>15). Then we 
compared sociodemographic and descriptive variables between these new 
groups with chi square test and ANOVA with Bonferroni post hoc test correction. 
We compared the groups in Decentering, Values and Public control of the 
experience of self with an ANOVA with Bonferroni post hoc test correction. 
Finally a correlation analysis between the number of ayahuasca experiences 
and process variables was made. 
3. Results  
The analysis in sociodemographic variables showed no differences in age, 
gender and education between ayahuasca users and non-users (Table 1).   
---Please, insert Table 1--- 
Related to other substance use, we found that ayahuasca users had a higher 
ratio of use in the last 12 months of MDMA (χ²=5.56; p=0.018), but there were 
no differences in the use of cocaine (χ²=3.13; p=0.077), cannabis (χ²=3.34; 
p=0.068), amphetamines (χ²=9.66; p=0.326), ketamine (χ²=0.05; p=0.824), 
opiates (χ²=0.97; p=0.326), LSD or other hallucinogens (χ²=2.47; p=0.116) in 
the last 12 months. There were no differences between the groups in 
somatisation (t=0.71; p=0.479), depression (t=0.48; p=0.635), anxiety (t=1.118; 
p=0.226) or the general index of BSI (t=60; p=0.550) and in psychoticism 
(t=0.48; p=0.633). 
Regarding the process variables, the group of ayahuasca users scored higher 
in Decentering and Positive self. There were no differences in Valued living, Life 
fulfilment, Self in general, Self in social relations or Self in close relations (Table 
2). 
---Please, insert Table 2--- 
After separating subjects who had experience with ayahuasca into two groups 
(subjects with less than 15 experiences and subjects with more than 15 
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experiences), both groups were compared again with the non-using group. The 
analysis in sociodemographic variables showed differences in age with higher 
mean age in the group with more experience but there were no differences in 
gender or education level between groups (Table 3). There were no differences 
between groups in Somatisation, Anxiety, Depression or Psychoticism. When 
comparing the three groups examining the consumption of other substances in 
the last six months, significant differences were observed only in the 
consumption of MDMA, with a higher consumption among the subjects with less 
than 15 experiences of ayahuasca (χ²=8.80; p=0.012). 
---Please, insert Table 3--- 
Comparing the three groups we observed significant differences in Decentering 
between the non-using group and AYA>15, and between AYA 1-15 and 
AYA>15. AYA 1-15 scored lower than AYA>15 in Valued living and higher in 
Self in social relations. AYA 1-15 scored higher also than both non-users and 
AYA>15 in Self in general. 
---Please, insert Table 4--- 
Correlations between the number of experiences with ayahuasca and 
Decentering, Valued living, Life fulfilment, Self in general, Self in social relations, 
Self in close relations and Positive self were not significant (Table 5). 
---Please, insert Table 5--- 
4. Discussion 
Although ayahuasca has been internationally popularized as a personal growth 
enhancing spiritual tool (Kjellgren et al., 2009), and there is some evidence 
confirming its psychotherapeutic potential (dos Santos et al., 2016b; Sanches 
et al., 2016), little research has been conducted in attempting to understand the 
psychological processes, or factors, that may explain its outcome effects (Soler 
et al., 2016; Thomas et al., 2013). In this study, we compared non-ayahuasca 
users with ayahuasca users in Decentering, Values and Public control of the 
experience of self, as well in classical psychopathological measures. 
As an initial result, there were no differences in psychopathology indexes of 
Somatisation, Depression, Anxiety and Psychoticism between users and non-
users. These results are in consonance with previous studies conducted in 
different cultural settings and countries where ayahuasca users did not show 
differences in psychopathology measures compared to non-users (Barbosa 
et al., 2016; Bouso et al., 2012, 2015).  
Regarding the process variables, ayahuasca users scored higher than non-
users in Decentering, but when ayahuasca users were separated into two 
subsamples, only the users that had taken ayahuasca on more than 15 
occasions scored higher than non-users and subjects with less experience. This 
result is in consonance with the only previous study using a measurement of 
Decentering where an improvement was found 24 hours after an ayahuasca 
experience compared with baseline (Soler et al., 2016). In that study the 
average number of ayahuasca experiences of the sample was 79. In contrast to 
these data, a previous study comparing a sample of cocaine users with a non-
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clinical sample, showed significantly lower scores in the group of consumers 
(Soler et al., 2014, data not shown). 
The increase in the ability to observe thoughts and feelings as temporary events 
in the mind, instead of seeing them as being true, has been suggested as an 
underlying mechanism that partially explains the beneficial effects of therapies 
such as Mindfulness Based Cognitive Therapy (MBCT) (Bieling et al., 2012) or 
Cognitive Behavioral Therapy (CBT) (Teasdale et al., 2002). Some data 
suggest that increases in Decentering may be particularly useful in preventing 
relapse on those receiving MBCT, and it is interesting to note that those 
patients treated only with antidepressant medications were also protected but 
changes in Decentering were observed (Bieling et al., 2012). In the same 
direction, with disorders such as Borderline Personality Disorder (BPD), both 
increases in Decentering and a reduction of BPD symptoms following 
Mindfulness intervention have been observed (Elices et al., 2016).  
Regarding „Values‟, the other psychological process variable studied here, there 
are many personal reports from ayahuasca users referring to the ayahuasca 
experiences as transformative ones that can be manifested as changes in 
personal values (Kavenská and Simonová, 2015). Previous studies found self-
reported changes in life attitudes and changes in personal values and life 
meaning after the administration of different doses of psilocybin (Griffiths et al., 
2008; Griffiths et al., 2011), and differences in life purpose and related variables 
in long-term ayahuasca users (Barbosa et al., 2016; Bouso et al., 2012). 
According to those studies, although we did not observe differences between 
ayahuasca users and non-users in Valued living and Life fulfilment, we found 
that subjects with more experience in ayahuasca use scored higher than 
subjects with less experience in Valued Living.  
Lastly, differences between ayahuasca users and non-users in „Public control of 
the experience of self‟ was not confirmed. Only scores in Positive self show 
differences between ayahuasca users and non-users, referred to creativity, 
spontaneity and a positive concept about one‟s self. After dividing the group of 
consumers into two groups and comparing non-users with users more than 15 
times and users less than 15 times, we observed that subjects with less than 15 
experiences with ayahuasca indicated a self more dependent on others in 
Social relations than subjects with more than 15 experiences, and also a self 
more dependent on others in „General‟ than subjects with more than 15 
experiences and naïve subjects.  
The positive self sub-index is formed by items that refer to creativity and 
spontaneity of the individual. Results when comparing subjects with and without 
experience in ayahausca consumption are similar to previous studies that 
describe enhancement of creativity after ayahuasca consumption (Frecksa 
2012). „Positive self‟ is not a construct described in contextual models, 
characterized by giving more importance to the function of thoughts than to their 
positive or negative content, but in this case, „Positive self‟ refers to creativity 
and spontaneity that in our opinion is related to flexibility of adaptation, the main 
objective of psychotherapies, especially ACT. Changes in personality after 
psychedelic experiences are also described in other studies. Recent research 
has found changes in the personality domain of „Openness to experience‟ 
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months after the administration of psilocybin (MacLean et al., 2011) and few 
weeks after an LSD (Lysergic Acid Diethylamide) experience (Carhart-Harris 
et al., 2016), as well as in a recent study comparing personality traits between 
regular ayahuasca users and non-users (Barbosa et al., 2016). Another study 
comparing personality traits between long-term ayahuasca users and non-users 
showed higher scores in the former of “Self-transcendence” (Bouso et al., 2012), 
a personality trait highly correlated with Openness to experience (De Fruyt et al., 
2000). 
The lower values reported by the less experienced ayahuasca users in “Valued 
living” and in some variables of “Public control of self” can reflect a state that 
motivates the search for solutions to issues via the consumption of ayahuasca. 
It can also reflect the crises described in the beginning of the psychedelic 
therapy process, where subjects question their previous behavior when they 
have low self-esteem and little in the way of defense mechanisms (Twemlow 
and Bowen, 1979). The higher scores in Decentering in experienced subjects 
would support this long-term therapeutic effect. 
According to this, the ayahuasca-induced experience would not only be related 
to a cathartic reaction, but it would be integrated as part of a positive self, 
allowing these benefits to be integrated as part of daily life. Regarding this, 
another phenomena related to the research of the self that should be 
investigated in the future is the possible adverse effect of psychedelics known 
as “ego inflation” (Nour et al., 2016) in order to have more knowledge regarding 
the practical consequences of the transformation in the self that can be 
observed in ayahuasca and/or other psychedelic users. 
One of the limitations of this study is that the evaluation was performed solely 
with self-report questionnaires. We think that it would be very interesting to 
explore more specific measurements to evaluate changes in consciousness in 
daily life and behavioural regulation through values as it could be changes in 
diet, conception of spiritual world, family, job, etc., that are contributing to 
changes. Another limitation of the study is the lack of information about the 
context, dosage and acute effects of ayahuasca use. In naturalistic studies it is 
difficult to assign the results observed specifically to ayahuasca usage, it being 
impossible to separate the pharmacological effects of ayahuasca from the 
context and the ritual setting. None of our study subjects took ayahuasca just 
for recreational purposes or in recreational settings. One last limitation related 
to the retrospective approach of this study is that it is also impossible to know if 
some of the differences found are because of ayahuasca use or because of 
pre-existing personality traits, or even to the differences due to MDMA use in 
the last 12 months between groups, since MDMA has shown promising results 
as a coadjutant in psychotherapy processes (Feduccia et al., 2018). Thus, the 
retrospective nature of self-report questionnaires in a potentially heterogeneous 
sample may further limit the generalizability of the results. Future prospective 
studies should be conducted to investigate this issue.  
To summarize, these results confirm that ayahuasca use is related to a basic 
process linked to therapeutic change: Decentering. Given these results we may 
assume that more sessions would result in a better outcome on the target 
processes, but this is not confirmed since we did not find any correlation 
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between the number of sessions and measurements of Decentering, Values or 
Self. It is likely that variables such as individual differences, context of use, and 
the post session integration work are very important for the optimization of the 
therapeutic effects of ayahuasca. Other authors have emphasized the 
importance of the setting where ayahuasca is used in order to produce a 
therapeutic effect (Frecska et al., 2016). We think that previous work focusing 
on the openness to experience, ability of observation, a low interventionist but 
attentive guide and a post session integration process with a metacognitive and 
validation approach could improve the therapeutic effect of the substance. It is 
necessary to continue studying the implicated factors in the therapeutic 
efficiency of ayahuasca use, both relating to the drug itself and the inner and 
outer context of the subject. 
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Tables 
Table 1: Sociodemographic data. 
 Non-users 
n=41 
Ayahuasca users 
n=81 
 
χ² 
Gender   3.256 
Male 34.9% 51.9%  
Female 65.1% 48.1%  
Studies   5.932 
Basic 2.4% 16.3%  
Bachelor or equivalent 12.2% 8.7%  
Professional training 17.1% 10%  
University 68.3% 65%  
   (s.d)   (s.d) t 
Age 42.4 (12.3) 41.7 (9.3) 0.325 
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Table 2: Mean comparisons between ayahuasca users and non-users in 
psychological measures. 
 Non-users 
(n=41) 
Ayahuasca 
users  
(n=81) 
 
  ´(s.d.)  ´(s.d.) t 
EQ (decentering) 40.29 (5.73) 42.82 (6.30) 2.280* 
Valued living 38.86 (6.40) 38.89 (6.55) 0.103 
Life fulfilment 21.11 (5.44) 21.85 (4.83) 0.809 
Self in social relations 16.70 (6.99) 17.94 (10.10) 0.699 
Self in close relations 26.74 (12.14) 24.44 (11.33) 1.156 
Self in general 24.00 (6.79) 26.00 (9.56) 1.266 
Positive self 26.00 (7.57) 28.78 (7.02) 2.272* 
*p≤ 0.05 
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Table 3. Sociodemographic characteristics in the three groups. 
 Non-users   
n=44 
AYA 1-15 times 
n=44 
AYA >15 times 
n=37 
χ² 
Gender    4.84 
Male 34.9% 45.5% 59.5%  
Female 65.1% 54.5% 40.5%  
Studies    9.43 
Basic 2.4% 11.6% 21.6%  
Bachelor or equivalent 12.2% 11.6% 5.4%  
Professional training 17.1% 7% 13.5%  
University 68.3% 69.8% 59.5%  
Age,   (s.d) 42.39 (12.32) 38.89 (7.48) 45.14 (10.22) F = 3.87* 
*p≤ 0.05 
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Table 4: ANOVA between the three groups. 
 Non-users 
  (s.d) 
AYA 1-15 
times 
  (s.d) 
AYA>15 
times 
  (s.d) 
F  Post hoc 
with 
Bonferroni 
EQ 
(Decenter-
ing) 
40.29 
(5.73) 
40.88 
(6.20) 
45.08 (5.71) 7.59** 0< +15** 
1-15 <+15* 
Valued 
Living  
38.86 
(6.36) 
36.73 
(6.62) 
41.46 (5.54) 5.81** 1-15 <+15* 
Life 
fulfilment 
21.12 
(5.44) 
21.36 
(4.99) 
22.43 (4.64) 0.747  
Self in 
social 
relations 
16.71 
(6.99) 
20.25 
(11.75) 
15.19 (6.90) 3.44*  
Self in 
close 
relations 
26.74 
(12.14) 
26.40 
(12.64) 
22.11 (9.18) 1.96  
Self in 
general 
24.00 
(6.77) 
28.48 
(10.16) 
23.05 (7.95) 4.89* 1-15 >+15* 
0<1-15* 
 
Positive 
self 
26.00 
(7.57) 
28.68 
(6.28) 
28.89 (7.89) 2.07  
*p≤ 0.05; **p≤0.005 
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Table 5. Pearson correlations between the number of ayahuasca experiences 
and the psychological measures. 
 EQ 
(Decentering) 
Valued 
living 
Life 
fulfilment 
Self 
social 
Self 
close 
Self 
general 
Number of 
experiences 
(1-100) 
0.175 0.151 0.107 -0.004 -0.056 -0.098 
 
